Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SenoRx, which develops, manufactures and sells minimally invasive medical devices for the diagnosis and treatment of breast cancer, has further extended its international expansion into five additional countries.
Subscribe to our email newsletter
SenoRx will begin marketing EnCor, its vacuum-assisted breast biopsy product, and its GelMark line of breast biopsy tissue markers through distributors in Australia, Korea, Spain, Portugal and Mexico.
SenoRx is partnering with local in-country distributors who have breast imaging or interventional radiology franchises in select markets.
Lloyd Malchow, president and CEO of SenoRx, said: “Our intention has been to enter additional countries on a step-wise basis to further capitalize on the interest from clinicians in our breast-care products that we see in a number of markets around the world. With the addition of these five new geographic markets, SenoRx will now have a presence in over 20 countries.”